Launched in 2005 by the Japanese Cancer Association and Debiopharm Group
The JCA-Mauvernay Award is organized each year in collaboration with the Japanese Cancer Association (JCA). This award has a total value of CHF 25’000 and it aims at recognizing outstanding achievements in the field of oncology amongst Japanese researchers, in both the fundamental and the clinical aspects.
In 2014, the JCA-Mauvernay Award celebrated its 10th anniversary (watch the video here).
The 2019 JCA-Mauvernay Award ceremony took place on Saturday September 29 during the 78th Annual Meeting of the Japanese Cancer Association that was held from 26 to 28 September 2019 at the Kyoto International Conference Center.
September 30, 2019
The Japanese Cancer Association and Debiopharm Announce Winners of the 2019 JCA-Mauvernay Award
September 28, 2018
The Japanese Cancer Association and Debiopharm Group Announce Winners of the 2018 JCA-Mauvernay Award
September 29, 2017
The Japanese Cancer Association and Debiopharm Group Announce Winners of the 2017 JCA-Mauvernay Award